- Bausch is seeking a court order blocking copies until the patents have expired, according to
complaintfiled Thursday in federal court in Wilmington, Delaware
- Patents expire in June 2024; February and June 2025; February 2026; September 2027; February, July and October 2029; and March 2030, according to
- Closely held
Alfasigmaowns 13 of the patents and exclusively licenses them to Bausch, complaint says
- Xifaxan had sales of $1.45 billion in 2019, 16.9% of ...
March 27, 2020, 2:17 PM